Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey

Abstract Introduction We aim to assess the real-world, US patient-reported impact of ankylosing spondylitis (AS) on quality of life (QOL) across physical, discomfort, social, and emotional domains. Methods Demographic and QOL data were collected from a random sample of patients associated with the S...

Full description

Bibliographic Details
Main Authors: James T. Rosenbaum, Lisa Pisenti, Yujin Park, Richard A. Howard
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-05-01
Series:Rheumatology and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40744-019-0160-8
_version_ 1811337893761777664
author James T. Rosenbaum
Lisa Pisenti
Yujin Park
Richard A. Howard
author_facet James T. Rosenbaum
Lisa Pisenti
Yujin Park
Richard A. Howard
author_sort James T. Rosenbaum
collection DOAJ
description Abstract Introduction We aim to assess the real-world, US patient-reported impact of ankylosing spondylitis (AS) on quality of life (QOL) across physical, discomfort, social, and emotional domains. Methods Demographic and QOL data were collected from a random sample of patients associated with the Spondylitis Association of America (SAA) from July to December 2017. QOL measures were based on the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) questionnaire. The survey evaluated AS impact on the physical domain on the day of survey participation and impact on the discomfort, social, and emotional domains within the week before participation. A 3:1 (male to female) weighting was performed to reflect the reported prevalence of AS in US adults. Results Of 820 respondents who completed the survey, 716 self-reported receiving an AS diagnosis from their doctor and were included in this analysis (mean age, 55.5 years; 46.9% male). The mean total EASi-QoL score was 28.9 (weighted); overall, 33.7%, 31.7%, and 34.7% of respondents, respectively, reported a low (EASi-QoL score 0–17), a medium (18–35), and a high (≥ 36) impact of AS on QOL. The physical domain was most impacted; 41.9% of respondents had an EASi-QoL score ≥ 10 (weighted). Women were significantly more likely than men to report a high impact of AS on all QOL domains. Biologic users reported an impact on QOL comparable with the impact on QOL of nonsteroidal anti-inflammatory drug use. AS also impacted lifestyle characteristics, including career choice and sports participation. Conclusion AS negatively impacted all QOL domains analyzed. The incorporation of subjective measures of disease into disease evaluation should be considered. Funding Novartis Pharmaceuticals Corporation and UCB, Inc. Plain Language Summary Plain language summary available for this article.
first_indexed 2024-04-13T18:01:46Z
format Article
id doaj.art-7f50d82bf5a749ab85143a263d2692ec
institution Directory Open Access Journal
issn 2198-6576
2198-6584
language English
last_indexed 2024-04-13T18:01:46Z
publishDate 2019-05-01
publisher Adis, Springer Healthcare
record_format Article
series Rheumatology and Therapy
spelling doaj.art-7f50d82bf5a749ab85143a263d2692ec2022-12-22T02:36:13ZengAdis, Springer HealthcareRheumatology and Therapy2198-65762198-65842019-05-016335336710.1007/s40744-019-0160-8Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact SurveyJames T. Rosenbaum0Lisa Pisenti1Yujin Park2Richard A. Howard3Oregon Health & Science UniversityUCB, Inc.Novartis Pharmaceuticals CorporationSpondylitis Association of AmericaAbstract Introduction We aim to assess the real-world, US patient-reported impact of ankylosing spondylitis (AS) on quality of life (QOL) across physical, discomfort, social, and emotional domains. Methods Demographic and QOL data were collected from a random sample of patients associated with the Spondylitis Association of America (SAA) from July to December 2017. QOL measures were based on the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) questionnaire. The survey evaluated AS impact on the physical domain on the day of survey participation and impact on the discomfort, social, and emotional domains within the week before participation. A 3:1 (male to female) weighting was performed to reflect the reported prevalence of AS in US adults. Results Of 820 respondents who completed the survey, 716 self-reported receiving an AS diagnosis from their doctor and were included in this analysis (mean age, 55.5 years; 46.9% male). The mean total EASi-QoL score was 28.9 (weighted); overall, 33.7%, 31.7%, and 34.7% of respondents, respectively, reported a low (EASi-QoL score 0–17), a medium (18–35), and a high (≥ 36) impact of AS on QOL. The physical domain was most impacted; 41.9% of respondents had an EASi-QoL score ≥ 10 (weighted). Women were significantly more likely than men to report a high impact of AS on all QOL domains. Biologic users reported an impact on QOL comparable with the impact on QOL of nonsteroidal anti-inflammatory drug use. AS also impacted lifestyle characteristics, including career choice and sports participation. Conclusion AS negatively impacted all QOL domains analyzed. The incorporation of subjective measures of disease into disease evaluation should be considered. Funding Novartis Pharmaceuticals Corporation and UCB, Inc. Plain Language Summary Plain language summary available for this article.http://link.springer.com/article/10.1007/s40744-019-0160-8Ankylosing spondylitisEpidemiological monitoringPatient-reported outcomesQuality of lifeQualitative research
spellingShingle James T. Rosenbaum
Lisa Pisenti
Yujin Park
Richard A. Howard
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
Rheumatology and Therapy
Ankylosing spondylitis
Epidemiological monitoring
Patient-reported outcomes
Quality of life
Qualitative research
title Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
title_full Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
title_fullStr Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
title_full_unstemmed Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
title_short Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
title_sort insight into the quality of life of patients with ankylosing spondylitis real world data from a us based life impact survey
topic Ankylosing spondylitis
Epidemiological monitoring
Patient-reported outcomes
Quality of life
Qualitative research
url http://link.springer.com/article/10.1007/s40744-019-0160-8
work_keys_str_mv AT jamestrosenbaum insightintothequalityoflifeofpatientswithankylosingspondylitisrealworlddatafromausbasedlifeimpactsurvey
AT lisapisenti insightintothequalityoflifeofpatientswithankylosingspondylitisrealworlddatafromausbasedlifeimpactsurvey
AT yujinpark insightintothequalityoflifeofpatientswithankylosingspondylitisrealworlddatafromausbasedlifeimpactsurvey
AT richardahoward insightintothequalityoflifeofpatientswithankylosingspondylitisrealworlddatafromausbasedlifeimpactsurvey